Stephens Inc. AR trimmed its position in UnitedHealth Group Inc (NYSE:UNH) by 4.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 45,785 shares of the healthcare conglomerate’s stock after selling 2,328 shares during the quarter. Stephens Inc. AR’s holdings in UnitedHealth Group were worth $10,094,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the stock. Calton & Associates Inc. acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $1,406,000. Claraphi Advisory Network LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $1,289,000. American Century Companies Inc. boosted its position in UnitedHealth Group by 1.4% in the fourth quarter. American Century Companies Inc. now owns 4,943,741 shares of the healthcare conglomerate’s stock valued at $1,089,897,000 after buying an additional 67,545 shares in the last quarter. Nicolet Bankshares Inc. boosted its position in UnitedHealth Group by 13.8% in the fourth quarter. Nicolet Bankshares Inc. now owns 2,300 shares of the healthcare conglomerate’s stock valued at $507,000 after buying an additional 279 shares in the last quarter. Finally, Raymond James Trust N.A. boosted its position in UnitedHealth Group by 0.8% in the fourth quarter. Raymond James Trust N.A. now owns 56,784 shares of the healthcare conglomerate’s stock valued at $12,518,000 after buying an additional 467 shares in the last quarter. 86.83% of the stock is currently owned by institutional investors and hedge funds.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,400 shares of UnitedHealth Group stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $229.87, for a total value of $2,390,648.00. Following the completion of the sale, the director now directly owns 1,781,657 shares of the company’s stock, valued at $409,549,494.59. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction on Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the completion of the sale, the director now directly owns 76,637 shares of the company’s stock, valued at $18,881,824.06. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 30,598 shares of company stock valued at $7,280,073. Insiders own 0.89% of the company’s stock.
UnitedHealth Group stock opened at $227.86 on Monday. The stock has a market cap of $220,491.70, a price-to-earnings ratio of 21.28, a P/E/G ratio of 1.33 and a beta of 0.74. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a fifty-two week low of $162.74 and a fifty-two week high of $250.79.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.11 earnings per share. equities analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 28.01%.
A number of brokerages have recently commented on UNH. Cantor Fitzgerald reiterated a “buy” rating and set a $225.00 price target on shares of UnitedHealth Group in a report on Monday, November 27th. Wells Fargo reiterated an “outperform” rating and set a $245.00 price target (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $215.00 to $225.00 and gave the stock an “outperform” rating in a report on Wednesday, November 29th. Credit Suisse Group reiterated a “positive” rating and set a $240.00 price target (up previously from $233.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Finally, Royal Bank of Canada lifted their price target on shares of UnitedHealth Group to $244.00 and gave the stock an “outperform” rating in a report on Wednesday, November 29th. They noted that the move was a valuation call. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $245.14.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) Position Cut by Stephens Inc. AR” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://ledgergazette.com/2018/03/19/unitedhealth-group-inc-unh-position-cut-by-stephens-inc-ar.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.